Consortium Spotlight: Advancing Discoveries in Mitochondrial Diseases Dakota Campbell Wed, 06/01/2022 - 14:59
North American Mitochondrial Disease Consortium (NAMDC) logo

The North American Mitochondrial Disease Consortium (NAMDC) was established to create a network of clinicians and clinical investigators in North America who follow sizeable numbers of patients with mitochondrial diseases and are involved or interested in mitochondrial research. Here, Principal Investigator (PI) Michio Hirano, MD, shares the history of the consortium, current research, and future plans.

Consortium Spotlight: Advancing Discoveries in Neurodevelopmental Disorders Dakota Campbell Thu, 04/14/2022 - 10:28
Developmental Synaptopathies Consortium logo

The Developmental Synaptopathies Consortium (DSC) is a network of experts studying three rare genetic syndromes—tuberous sclerosis complex (TSC), Phelan-McDermid syndrome (PMS), and PTEN hamartoma tumor syndrome (PHTS)—that often cause autism spectrum disorder and intellectual disability. Here, program manager Rajna Filip-Dhima, MS, and principal investigator Mustafa Sahin, MD, PhD, share the history of the consortium, current research, and future plans. 

Consortium Spotlight: Advancing Discoveries in Mucociliary Clearance Diseases Dakota Campbell Fri, 03/11/2022 - 14:52
Genetic Disorders of Mucociliary Clearance Consortium logo

The Genetic Disorders of Mucociliary Clearance Consortium (GDMCC) is a network of experts working together to better understand rare and genetic conditions leading to impairments in lung defenses and suppurative respiratory disorders, including primary ciliary dyskinesia, cystic fibrosis, primary immunodeficiencies, and idiopathic bronchiectasis. Here, principal investigators Stephanie Davis, MD, and Thomas Ferkol, MD, share the history of the consortium, current research, and future plans. 

Consortium Spotlight: Advancing Discoveries in Brittle Bone Disorders Dakota Campbell Wed, 11/03/2021 - 11:58
Members of the Brittle Bone Disorders Consortium

The Brittle Bone Disorders Consortium (BBDC) brings together physicians, researchers, and educators to learn more about osteogenesis imperfecta (OI), a genetic disorder that mainly affects the development of the bones. The goal is to develop new and better treatments for patients with OI. Here, principal investigator Brendan Lee, MD, PhD, and Vernon Sutton, MD, share the history of the consortium, current research, and future plans.

Consortium Spotlight: Advancing Discoveries in Brain Vascular Malformations Dakota Campbell Thu, 10/07/2021 - 09:54
Headshot of Helen Kim, PhD
Helen Kim, PhD

Since its initial funding in 2009, the Brain Vascular Malformation Consortium (BVMC) has conducted clinical research and improved the care of patients with brain vascular malformations, conditions in which blood vessels of the brain are affected. Here, Helen Kim, PhD, principal investigator of the BVMC, shares the history of the consortium, current research, and future plans.

Consortium Spotlight: New Consortium Targets Congenital and Perinatal Infections Dakota Campbell Tue, 01/26/2021 - 14:20
CPIC Central Unit personnel

The Congenital and Perinatal Infections Consortium (CPIC) brings together a coalition of 29 academic medical centers that have a longstanding history of research in pediatric infectious diseases with community and industry stakeholders. It is one of five new consortia to join the Rare Diseases Clinical Research Network in the latest funding cycle. Here, CPIC leaders share insights on the group’s goals, research projects, and next steps.

Spotlight on RDCRN Consortia: Vasculitis Clinical Research Consortium Anonymous (not verified) Fri, 01/06/2012 - 10:53

The Vasculitis Clinical Research Consortium (VCRC) is an international, multi-center, clinical research infrastructure for the study of vasculitis.